BioSpace News Archive

Drug Development

Galmed Pharmaceuticals Announces The Beginning Of Enrollment In Its Phase IIb ARREST Trial For The Treatment Of NASH, As Well As The Expansion Of The Study To The United States

March 9, 2015
·
3 min read
FDA

Basilea Pharmaceutica Reports U.S. FDA Approval Of Isavuconazole For The Treatment Of Invasive Aspergillosis And Invasive Mucormycosis

March 9, 2015
·
10 min read
Business

Innate Pharma Collaborates With NCIC Clinical Trials Group On The Phase I/II Trial Of IPH2201 In Ovarian Cancer

March 9, 2015
·
6 min read
Nexvet Provides Update On Pivotal Field Safety And Efficacy Study For NV-01

March 9, 2015
·
6 min read
Business

Sucampo Pharmaceuticals, Inc. To Return All Licenses For Unoprostone Isopropyl To R-Tech Ueno

March 9, 2015
·
3 min read
Drug Development

Emergent BioSolutions And MorphoSys AG Initiate Phase 1 Clinical Study To Evaluate The Novel Oncology Immunotherapeutic MOR209/ES414 For Prostate Cancer

March 9, 2015
·
8 min read
Business

Hemispherx Biopharma Enters A Collaboration With Emerge Health For The Commercialization Of Ampligen For Chronic Fatigue Syndrome (CFS) In Australia And New Zealand

March 9, 2015
·
6 min read
Drug Development

Ultragenyx Pharmaceuticals Announces Presentation Of Disease Burden Data In Adult Patients With X-Linked Hypophosphatemia

March 9, 2015
·
7 min read
Drug Development

Heat Biologics Receives U.S. FDA Fast Track Designation For HS-410 (Vesigenurtacel L) In Combination With BCG For The Treatment Of Non-Muscle Invasive Bladder Cancer

March 9, 2015
·
4 min read
BioMidwest

Van Andel Institute And Neiman Marcus Host The Art Of Fashion And Research

March 9, 2015
·
1 min read